【ChiCTR2100048830】Antonello NICOLINI: please submit an approval letter of IRB Do not forget the lungs: I/E mode physiotherapy for people recovering from COVID-19. Preliminary feasibility
ChiCTR2100048830
结束
/
/
/
2021-07-18
/
/
post covid 19 syndrome
Antonello NICOLINI: please submit an approval letter of IRB Do not forget the lungs: I/E mode physiotherapy for people recovering from COVID-19. Preliminary feasibility
Do not forget the lungs: I/E mode physiotherapy for people recovering from COVID-19. Preliminary feasibility study
16039
evaluation of respiratory function parameters quality of life scores exercise capacity befora and after teatment with T-PEP 4 in patients with post COVID 19 syndrome
单臂
回顾性研究
na
/
no founding sources
/
20
/
2021-01-18
2021-07-01
/
1. Aged >=18 years 2. Discharged from hospital after a COVID19 pneumonia 3. In spontaneous breathing 4. Able to breathe keeping a mouthpiece 5. Mild to moderate obstructive syndrome at spirometry (12) and at least one symptom among: (1) Breathlessness or feeling as “I can't take a deep breath” or inability to yawn (2) Cough (3) Chest pain/Chest tightness (4) Dyspnoea (at rest or during normal ADL) (5) Oxygen desaturation >=4% during daily physical activities；
请登录查看Already on treatment with NIV or CPAP before COVID 19 - Oxygen supplementation at rest - Inability or refusal to collaborate - Lack of informed consent - Severe obstructive syndrome ( forced expiratory volume 1 second - FEV1 - < 50% )；
请登录查看asl4 chiavarese chiavari
/
asl4 chiavarese chiavari的其他临床试验
意大利Genoa sestri levante的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29